Monitoring and Managing Neurotoxicity Following CAR-T Cell Therapy

Highlighting the importance of closely monitoring immune effector cell associated neurotoxicity syndrome development post-CAR-T cell therapy, focusing on risk factors such as age and lymphoma burden. Discusses the ICE score for patient assessment and the protocol for intervention in case of functional decline.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app